The CD56 test is used to evaluate the density of natural killer cells, known as NK cells, in the endometrial lining. It may help assess the immune environment inside the uterus, especially in patients who experience recurrent miscarriages or who cannot achieve pregnancy despite the transfer of good-quality embryos.
For pregnancy to occur, the embryo must implant successfully into the endometrial lining. This process is not related only to embryo quality. The structure of the endometrial lining, hormonal balance, blood supply, immune system, and many molecular mechanisms play a role together.
Among these mechanisms, it is important for the immune system to respond appropriately to pregnancy. The presence of certain immune cells in the uterus at higher or lower densities than normal may affect the embryo implantation process.
What Is the CD56 Test?
The CD56 test is an evaluation that helps measure the density of natural killer cells in the endometrial lining. Natural killer cells are important components of the immune system and are also referred to in medicine as NK cells.
NK cells normally function as part of the body’s defense system. However, during pregnancy, the immune balance inside the uterus requires a different level of sensitivity. For the embryo to implant in the uterus, the immune system is expected to work in a way that supports this process.
If the density of NK cells in the endometrial lining is above or below average, the implantation process may be negatively affected in some patients. For this reason, the CD56 test may be considered especially in recurrent pregnancy losses and failed IVF attempts.
Why Is the CD56 Test Performed?
The CD56 test is performed to evaluate immune system-related factors that may affect embryo implantation. Especially if pregnancy does not occur despite the transfer of good-quality embryos in IVF treatment, the intrauterine environment may need to be examined in more detail.
The CD56 test may be used for the following purposes:
- To evaluate the density of NK cells inside the uterus
- To investigate possible immune-related factors in recurrent miscarriages
- To examine the intrauterine environment in recurrent IVF failures
- To evaluate the immunological status that may affect embryo implantation
- To help personalize the treatment plan
This test alone does not explain the cause of all pregnancy losses or failed IVF attempts. However, in the appropriate patient group, it may contribute to the evaluation process.
Who Is the CD56 Test Recommended For?
The CD56 test is not a routine test performed for every patient. It is generally requested by the doctor in certain clinical situations.
The CD56 test may be recommended for the following patients:
- Women with a history of two or more miscarriages
- Patients experiencing recurrent pregnancy loss
- Patients who cannot achieve pregnancy despite three or more good-quality embryo transfers
- Couples experiencing recurrent IVF failure
- Patients in whom implantation problems are suspected despite good embryo quality
- Situations where the intrauterine immune balance needs to be evaluated
For example, if pregnancy does not occur after several attempts despite the transfer of embryos that appear healthy in IVF treatment, the doctor may request additional examinations related to the endometrial lining and immune system. The CD56 test may be one of these evaluations.
How Is the CD56 Test Performed?
The CD56 test can be performed using a blood sample or a tissue sample taken from the endometrial lining. However, in most cases, examination of uterine tissue is preferred in order to assess the intrauterine immune environment more directly.
The test is usually planned for the period after ovulation. A small tissue sample taken from the endometrial lining is examined by specialist pathologists. This examination is performed using immunohistochemical methods, and the density of CD56-positive cells is evaluated.
The procedure is usually planned as follows:
- The patient’s menstrual cycle is monitored.
- The ovulation period is determined.
- A sample is usually taken from the endometrial lining between days 21 and 24 of the cycle.
- The collected tissue sample is sent to the pathology laboratory.
- The density of CD56-positive cells is evaluated.
- The result is interpreted together with the patient’s clinical history.
The exact day of the test may vary depending on the patient’s menstrual pattern and ovulation timing. Therefore, the timing should be determined by the doctor.
Is a Blood Sample or Uterine Tissue Preferred for the CD56 Test?
CD56 evaluation can also be performed using a blood sample. However, the NK cell ratio in the blood may not always accurately reflect the cell density in the endometrial lining.
Therefore, if embryo implantation and the intrauterine immune environment are being evaluated, examination through uterine tissue may be considered more meaningful. This is because the area that is important for pregnancy is directly the endometrial lining.
Still, which method will be preferred should be determined according to the patient’s condition and the physician’s clinical approach.
What Does a High CD56 Level Mean?
A high CD56 level may indicate that the density of NK cells in the endometrial lining is higher than expected. In some patients, this condition may be associated with immune responses that may make embryo implantation more difficult.
However, a high CD56 level alone does not represent a definitive diagnosis. The result must be evaluated together with the patient’s miscarriage history, IVF history, embryo quality, uterine structure, hormone levels, and other tests.
In patients with elevated CD56 levels, the doctor may consider certain treatment options aimed at balancing the immune system before embryo transfer.
What Is Done If the CD56 Level Is High?
If the CD56 level is found to be high, the treatment plan is prepared individually. First, the patient’s previous pregnancies, miscarriage history, IVF attempts, embryo quality, and intrauterine condition are evaluated together.
In some patients, treatments aimed at balancing the immune system before embryo transfer may be considered. These treatments may include supportive therapies such as intralipid administration. However, such applications must always be performed under medical supervision, with appropriate patient selection and correct timing.
The same treatment is not applied to every patient with high CD56 levels. The treatment decision should be based not only on the test result but on the entire clinical picture.
Does the CD56 Test Increase the Chance of Pregnancy?
The CD56 test is not a treatment that directly increases the chance of pregnancy. It is an examination that helps evaluate the intrauterine immune environment.
According to the test result, a personalized treatment plan can be created in suitable patients. If the implantation problem is thought to be related to the immune system, arranging the treatment plan accordingly may support the chance of pregnancy.
However, pregnancy success does not depend only on the CD56 result. Many factors affect success:
- The woman’s age
- Egg quality
- Sperm quality
- Embryo quality
- The condition of the endometrial lining
- Hormonal balance
- Genetic factors
- Immune system response
- Previous miscarriage or IVF history
Therefore, the CD56 test should be considered as part of a broader infertility and recurrent miscarriage evaluation.
What Should Be Known About the CD56 Test?
The CD56 test is a special test that may be used to evaluate the intrauterine immune balance in recurrent miscarriages and recurrent IVF failures. Especially in patients who do not achieve pregnancy despite good-quality embryo transfers, it may contribute to investigating factors that could affect the implantation process.
The result of this test does not provide a definitive decision on its own. The most appropriate approach is to evaluate the CD56 result together with the patient’s full clinical history. Whether the test should be performed, its timing, and possible treatments according to the result should be decided by a gynecology, obstetrics, and IVF specialist.
Frequently Asked Questions
What is the CD56 test?
The CD56 test evaluates the density of natural killer cells, known as NK cells, in the endometrial lining.
Who is the CD56 test performed for?
It may be recommended for patients who have experienced two or more miscarriages, recurrent IVF failure, or who cannot achieve pregnancy despite the transfer of good-quality embryos.
How is the CD56 test performed?
It is usually performed by examining a tissue sample taken from the endometrial lining after ovulation in a pathology laboratory.
What does a high CD56 level mean?
A high CD56 level may indicate that the density of NK cells in the endometrial lining is higher than expected. The result must be evaluated together with the clinical history.
Can high CD56 levels be treated?
In suitable patients, treatments aimed at balancing the immune system may be considered. The treatment decision must be made individually by the doctor.